Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Publication

Article

March 14, 2013

CURE

Spring 2013
Volume12
Issue 1

HPV-Related Cancers Rising

Author(s):

Elizabeth Whittington

Cases of HPV-related cancers are on the rise, specifically those associated with head and neck and anal cancers.

In January, the Annual Report to the Nation on the Status of Cancer revealed that while cancer deaths continue to decrease by a marginal amount, the number of cancer diagnoses related to human papillomavirus (HPV) is increasing, largely fueled by anal and head and neck cancers caused by the virus. Experts find this disconcerting because the rise in HPV-related cancers is largely preventable.

Certain strains of HPV are transmitted during sexual contact, and two approved vaccines, Gardasil and Cervarix, protect against the virus.

Gardasil has been approved to protect against cervical cancer in females ages 9 to 26. Additional studies have led to the vaccine being approved for prevention of genital warts, vulvar, vaginal and anal cancers, and for use in males ages 9 to 26. It is also believed to help prevent HPV-related oropharyngeal cancers. Unfortunately, vaccine rates continue to be low. Only a third of girls and less than 2 percent of boys have received the three doses needed to provide full protection. Controversy over vaccinating children to protect against sexually transmitted disease, the cost (around $400) and fear of side effects have likely led to the low vaccination rates. The Healthy People 2020 initiative, a plan sponsored by the U.S. Department of Health and Human Services, includes a goal of an 80 percent HPV vaccination rate for girls. The authors of the report expect the rate of vaccination to increase eventually, especially in males, which could have a significant impact on the number of anal and oropharyngeal cancers.

There have been gains in one HPV-related cancer, though. Cervical cancer rates have decreased, most likely attributed to early screening and detection with Pap smears.

Articles in this issue

Qigong could reduce depression in patients with breast cancer undergoing radiation
How Caregivers Adjust to Post-Cancer Life
HPV-Related Cancers Rising
Planning for an Unpredictable Cancer
Pipeline
Research Updates
Stars Team Up to Help Young Cancer Patient
Tool Helps Users Prepare for End-of-Life Discussion
National Women's Survivors Convention
Dr. Lacouture's Skin Care Guide for People Living with Cancer
Recalcitrant Cancer Research Act Becomes Law
Weighing the Consequences
Meet the Team
Sarcoma in the Young
Preparing for Chemoradiotherapy

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of bald man.
Image of Dr. Salani.
Image of man with black hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
Linda Ryan, a patient advocate
A panel of 3 experts on cervical cancer seated on chairs in a studio
Related Content
Advertisement
Image of woman holding her neck.
May 5th 2025

First-Line Keytruda Combo Elicits OS Results in Head and Neck Cancers

Ryan Scott
First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and neck squamous cell carcinoma.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma: © stock.adobe.com.
April 24th 2025

FDA Approves Penpulimab-kcqx For Nasopharyngeal Carcinoma

Alex Biese
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma.
Kate Weissman, a gynecologic cancer survivor
November 30th 2023

Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer

Alex Biese
Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
April 9th 2025

Breaking Down Treatment Options for Patients With Head and Neck Cancer

Alex Biese
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
Related Content
Advertisement
Image of woman holding her neck.
May 5th 2025

First-Line Keytruda Combo Elicits OS Results in Head and Neck Cancers

Ryan Scott
First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and neck squamous cell carcinoma.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma: © stock.adobe.com.
April 24th 2025

FDA Approves Penpulimab-kcqx For Nasopharyngeal Carcinoma

Alex Biese
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma.
Kate Weissman, a gynecologic cancer survivor
November 30th 2023

Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer

Alex Biese
Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
April 9th 2025

Breaking Down Treatment Options for Patients With Head and Neck Cancer

Alex Biese
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.